Success Metrics

Clinical Success Rate
72.0%

Based on 18 completed trials

Completion Rate
72%(18/25)
Active Trials
18(25%)
Results Posted
50%(9 trials)
Terminated
7(10%)

Phase Distribution

Ph phase_2
6
8%
Ph phase_1
2
3%
Ph phase_4
4
5%
Ph phase_3
2
3%
Ph not_applicable
41
56%

Phase Distribution

2

Early Stage

6

Mid Stage

6

Late Stage

Phase Distribution55 total trials
Phase 1Safety & dosage
2(3.6%)
Phase 2Efficacy & side effects
6(10.9%)
Phase 3Large-scale testing
2(3.6%)
Phase 4Post-market surveillance
4(7.3%)
N/ANon-phased studies
41(74.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.1%

18 of 29 finished

Non-Completion Rate

37.9%

11 ended early

Currently Active

18

trials recruiting

Total Trials

73

all time

Status Distribution
Active(26)
Completed(18)
Terminated(11)
Other(18)

Detailed Status

unknown18
Completed18
Recruiting13
Terminated7
Not yet recruiting6
Active, not recruiting5

Development Timeline

Analytics

Development Status

Total Trials
73
Active
18
Success Rate
72.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (3.6%)
Phase 26 (10.9%)
Phase 32 (3.6%)
Phase 44 (7.3%)
N/A41 (74.5%)

Trials by Status

active_not_recruiting57%
recruiting1318%
not_yet_recruiting68%
terminated710%
unknown1825%
enrolling_by_invitation23%
completed1825%
withdrawn45%

Recent Activity

Clinical Trials (73)

Showing 20 of 73 trialsScroll for more
NCT06869122

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates - UK

Recruiting
NCT06503744Not Applicable

Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer

Recruiting
NCT07521618Not Applicable

One-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and Ablation

Not Yet Recruiting
NCT07517640Phase 2

Combining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial

Not Yet Recruiting
NCT07503769Not Applicable

CHU Dual-Energy Ablation in Ventricular Arrhythmia

Enrolling By Invitation
NCT07497178Not Applicable

MRgFUS for Childhood Epilepsy

Not Yet Recruiting
NCT07487662Phase 2

TACE or Ablation Combined With Sintilimab and Ipilimumab N01 as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With Intermediate-High Recurrence Risk

Not Yet Recruiting
NCT07145177Phase 1

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Recruiting
NCT05524077Not Applicable

Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia

Active Not Recruiting
NCT05786625

Bronchoscopic Microwave Ablation of Lung Tissue

Active Not Recruiting
NCT07272356Not Applicable

Evaluation of Efficacy of Minimally Invasive Local Therapy for Lung Tumors and Its Impact on Breathing Function

Active Not Recruiting
NCT07092774

Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)

Active Not Recruiting
NCT01898221Phase 3

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

Completed
NCT05643209Not Applicable

Brugada Syndrome Substrate Characterization and Ablation

Recruiting
NCT03844399

(3D) Ultrasound Imaging Liver and Kidney

Recruiting
NCT00839566Phase 4

PAF-HEFT (Permanent Atrial Fibrillation in Heart Failure Trial)

Terminated
NCT06689488

Bronchoscopic Microwave Ablation of Lung Tissue in Surgical Candidates

Recruiting
NCT05707637

Bipolar Radio-frequency Ablation After Standard Unipolar Approach - Prospective Registry.

Recruiting
NCT06798961

Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)

Active Not Recruiting
NCT06725576

Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma

Recruiting

Drug Details

Intervention Type
DEVICE
Total Trials
73